Latest News

Preliminary Data on Therapy-Free Remission with Dupilumab for Pediatric Atopic Dermatitis
Preliminary Data on Therapy-Free Remission with Dupilumab for Pediatric Atopic Dermatitis

July 13th 2024

A significant proportion of pediatric patients with AD achieved and maintained clinical remission with dupilumab, according to a poster presented at the SPD's annual meeting.

Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis
Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis

July 13th 2024

Top Insights From 6 Influential Leaders in AD
Top Insights From 6 Influential Leaders in AD

July 11th 2024

Management of Atopic Dermatitis With Hand and Foot Involvement
Management of Atopic Dermatitis With Hand and Foot Involvement

July 10th 2024

Continued Efficacy of Dupilumab for Children with AD
Continued Efficacy of Dupilumab for Children with AD

July 9th 2024

© 2024 MJH Life Sciences

All rights reserved.